Concord Healthcare Achieves Milestone with China's First Proton Therapy for Choroidal Malignant Melanoma Concord Healthcare has successfully completed China's first proton therapy for choroidal malignant melanoma, providing a new treatment option.

Concord Healthcare Achieves Milestone with China's First Proton Therapy for Choroidal Malignant Melanoma #China #Guangzhou #Proton_Therapy #Concord_Healthcare #Choroidal_Melanoma